Skip to content
2000
Volume 1, Issue 1
  • ISSN: 2211-5560
  • E-ISSN: 2211-5579

Abstract

The paper provides a brief summary of current preclinical and clinical evidences of dopaminergic system involvement in OCD pathophysiology. We also provide an overview of effectiveness and long-term safety of dopaminergic agents in the treatment of resistant OCD.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpsp/10.2174/2211556011201010044
2012-02-01
2025-10-19

  • From This Site

    /content/journals/cpsp/10.2174/2211556011201010044
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/cpsp/10.2174/2211556011201010044
Loading

  • Article Type:     Research Article
Keyword(s): amphetamine; antipsychotics augmentation; aripiprazole; cocaine; dopamine agents; endogenous; Haloperidol; OCD; olanzapine; ondansetron; placebo-controlled; quetiapine; resistant-OCD; risperidone augmentation; Sydenham's chorea

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test